Johnson & Johnson
JNJ
#23
Rank
NZ$1.086 T
Marketcap
NZ$451.44
Share price
3.99%
Change (1 day)
80.77%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): NZ$14.91

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$15.49. In 2025 the company made an earnings per share (EPS) of NZ$19.75 an increase over its 2024 EPS that were of NZ$11.86.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$14.91-24.49%
2025NZ$19.7566.46%
2024NZ$11.86-53.6%
2023NZ$25.56111.16%
2022NZ$12.11-13.84%
2021NZ$14.0541.81%
2020NZ$9.91-18.92%
2019NZ$12.2221.2%
2018NZ$10.081125.3%
2017NZ$0.82-92.23%
2016NZ$10.597.37%
2015NZ$9.86-4.16%
2014NZ$10.2918.1%
2013NZ$8.7124.88%
2012NZ$6.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.44-19.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-85.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.40-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.36-58.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$50.03 223.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.54-70.70%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$12.14-21.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$15.05-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.31-59.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.89-55.52%๐Ÿ‡ฌ๐Ÿ‡ง UK